Synthesis and transporter binding properties of 3 beta-(4'-alkyl-, 4'-alkenyl-, and 4'-alkynylphenyl)nortropane-2 beta-carboxylic acid methyl esters: serotonin transporter selective analogs

J Med Chem. 1996 Sep 27;39(20):4027-35. doi: 10.1021/jm960409s.

Abstract

New methods for the synthesis of 3 beta-(4'-alkyl-, 4'-alkenyl-, and 4'-alkynylphenyl)nortropane-2 beta-carboxylic acid methyl esters 2-4, respectively, were developed. These methods involved coupling of the appropriate organometallic reagents to 3 beta-(4'-iodophenyl)tropane-2 beta-carboxylic acid methyl ester (6a, RTI-55) or to an N-protected derivative of 6a followed by N-demethylation or removal of the protecting group. Some analogs were prepared by catalytic reduction of the alkene and alkene analogs 3 and 4 or by isomerization of the alkenes 3. The analogs 2-4 were evaluated for inhibition of radioligand binding to the serotonin (5-HT), dopamine (DA), and norepinephrine (NE) transporters. 3 beta-(4'-Isopropenyl- and 4'-cis-propenylphenyl)nortropane-2 beta-carboxylic acid methyl esters (3b,d), which possessed IC50 values of 0.6 and 1.15 nM, respectively, were the most potent analogs at the 5-HT transporter, and with NE/5-HT IC50 ratios of 240 and 128 nM, respectively, they were selective for the 5-HT relative to the NE transporter. Since interaction with the serotonin transporter may modulate the pharmacological effects resulting from binding to the dopamine transporter, 3 beta-(4'-isopropenylphenyl)tropane-2 beta-carboxylic acid methyl ester (11b) which has good affinity for both the 5-HT and DA transporters but low affinity at the NE transporter may be useful for studying this interaction.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Binding, Competitive
  • Brain / metabolism
  • Carrier Proteins / metabolism*
  • Cocaine / analogs & derivatives
  • Cocaine / metabolism
  • Dopamine / metabolism
  • Dopamine Uptake Inhibitors
  • Fluoxetine / analogs & derivatives
  • Fluoxetine / metabolism
  • Membrane Glycoproteins / metabolism*
  • Membrane Transport Proteins*
  • Molecular Structure
  • Nerve Tissue Proteins*
  • Norepinephrine / antagonists & inhibitors
  • Norepinephrine / metabolism
  • Nortropanes / chemical synthesis*
  • Nortropanes / metabolism
  • Paroxetine / metabolism
  • Radioligand Assay
  • Rats
  • Selective Serotonin Reuptake Inhibitors
  • Serotonin / metabolism
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Receptor Agonists / chemistry*
  • Serotonin Receptor Agonists / metabolism
  • Structure-Activity Relationship
  • Tropanes / chemical synthesis*
  • Tropanes / metabolism

Substances

  • 3-(4'-isopropenylphenyl)nortropane-2-carboxylic acid methyl ester
  • 3-(4'-isopropenylphenyl)tropane-2-carboxylic acid methyl ester
  • 3-(4'-propenylphenyl)nortropane-2-carboxylic methyl ester
  • Carrier Proteins
  • Dopamine Uptake Inhibitors
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Nortropanes
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Receptor Agonists
  • Serotonin Uptake Inhibitors
  • Slc6a4 protein, rat
  • Tropanes
  • Fluoxetine
  • nisoxetine
  • Serotonin
  • Paroxetine
  • (1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester
  • Cocaine
  • Dopamine
  • Norepinephrine